BioNTech SE (BNTX)
NASDAQ: BNTX
· Real-Time Price · USD
110.88
0.11 (0.10%)
At close: Aug 22, 2025, 3:59 PM
110.16
-0.65%
After-hours: Aug 22, 2025, 04:47 PM EDT
0.10% (1D)
| Bid | 110.15 |
| Market Cap | 26.66B |
| Revenue (ttm) | 2.88B |
| Net Income (ttm) | -347.44M |
| EPS (ttm) | -1.66 |
| PE Ratio (ttm) | -66.8 |
| Forward PE | -26.25 |
| Analyst | Buy |
| Ask | 111.12 |
| Volume | 389,910 |
| Avg. Volume (20D) | 837,456 |
| Open | 110.75 |
| Previous Close | 110.77 |
| Day's Range | 110.75 - 112.90 |
| 52-Week Range | 81.20 - 131.49 |
| Beta | 1.24 |
About BNTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BNTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BNTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
BioNTech SE is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+2.51%
BioNTech shares are trading higher after the compa...
Unlock content with
Pro Subscription
2 months ago
+18.05%
BioNTech shares are trading higher after the company entered into an agreement with Bristol Myers Squibb to advance bispecific antibody BNT327 for solid tumors.
